College of Public Health.
College of Nursing.
Pediatrics. 2024 Apr 1;153(4). doi: 10.1542/peds.2023-062424.
Despite the increasing prevalence of vaping e-cigarettes among adolescents, there remains a lack of population-level assessments regarding the objective measurement of nicotine exposure.
This study analyzed a nationally representative sample of adolescents aged 13 to 17 years from Wave 5 of the Population Assessment of Tobacco and Health Study conducted between 2018 and 2019. Urinary nicotine metabolites, including cotinine and trans-3'-hydroxycotinine (3-HC), were assessed among exclusive nonnicotine e-cigarette users (n = 56), exclusive nicotine e-cigarette users (n = 200), and nonusers (n = 1059). We further examined nicotine exposure by past 30-day vaping frequency (ie, occasional [1-5 days], intermittent [6-19 days], and frequent [20+ days]) and flavor types among nicotine e-cigarette users. Multivariable linear regressions tested pairwise group effects, and biomarkers were normalized by the log transformation.
Compared with nonusers, both nonnicotine and nicotine e-cigarette users exhibited higher levels of cotinine and 3-HC. Nicotine e-cigarette users had mean cotinine concentrations (61.3; 95% confidence interval, 23.8-158.0, ng/mg creatinine) approximately 146 times higher (P < .0001) than nonusers (0.4; 0.3-0.5), whereas nonnicotine users (4.9; 1.0-23.2) exhibited cotinine concentrations ∼12 times higher (P = .02). Among nicotine e-cigarette users, the levels of cotinine and 3-HC increased by vaping frequency, with cotinine increasing from 10.1 (2.5-40.1) among occasional users to 73.6 (31.8-170.6) among intermittent users and 949.1 (482.5-1866.9) among frequent users. Nicotine exposure was not significantly different by flavor type.
E-cigarette use poses health-related risks resulting from nicotine exposure among adolescents. Comprehensive regulations of e-cigarette products and marketing, vaping prevention, cessation, and public policies are needed to prevent youth from developing nicotine addiction.
尽管青少年使用蒸气电子烟的比例不断上升,但对于尼古丁暴露的客观测量,仍然缺乏人群水平的评估。
本研究分析了 2018 年至 2019 年期间进行的人口烟草与健康评估研究第五波中年龄在 13 至 17 岁的全国代表性青少年样本。在仅使用非尼古丁蒸气电子烟的使用者(n = 56)、仅使用尼古丁蒸气电子烟的使用者(n = 200)和非使用者(n = 1059)中,评估了尿中尼古丁代谢物,包括可替宁和反式-3'-羟基可替宁(3-HC)。我们进一步检查了尼古丁暴露的情况,包括过去 30 天的蒸气电子烟使用频率(即偶尔[1-5 天]、间歇性[6-19 天]和频繁[20+天])和尼古丁蒸气电子烟使用者的口味类型。多元线性回归检验了两两组间的效应,并且通过对数转换对生物标志物进行了标准化。
与非使用者相比,非尼古丁和尼古丁蒸气电子烟使用者的可替宁和 3-HC 水平均较高。尼古丁蒸气电子烟使用者的可替宁浓度(61.3;95%置信区间,23.8-158.0,ng/mg 肌酐)比非使用者高约 146 倍(P <.0001)(0.4;0.3-0.5),而非尼古丁使用者(4.9;1.0-23.2)的可替宁浓度高约 12 倍(P =.02)。在尼古丁蒸气电子烟使用者中,可替宁和 3-HC 的水平随蒸气电子烟使用频率的增加而升高,偶尔使用者的可替宁浓度从 10.1(2.5-40.1)升高到间歇性使用者的 73.6(31.8-170.6)和频繁使用者的 949.1(482.5-1866.9)。不同口味类型的尼古丁暴露差异无统计学意义。
蒸气电子烟的使用会导致青少年尼古丁暴露,从而带来健康风险。需要全面监管蒸气电子烟产品和营销、开展蒸气电子烟预防、戒烟和公共政策,以防止青少年对尼古丁产生依赖。